Skip to content

Anti-Borrelia burgdorferi IgG Antibody (Serum/Plasma) – Fluorescent Immunoassay

Published: August 9, 2026Updated: August 15, 2026

This blood test detects antibodies to *Borrelia burgdorferi*, the bacterium responsible for Lyme disease, using a fluorescent immunoassay method. It helps identify past or current infection.

Quick summary

["This test checks for Lyme disease antibodies in your blood, aiding diagnosis after tick exposure or symptoms."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 15, 2026Editorial policy

Key facts at a glance

LOINC
48893-2
Short code
COXBG2
Synonyms
C burnet Ph2 IgG Titr Fld IF
Category
chemistry
Sample
serum
Container
Sterile, leak-proof container; red-top or serum separator tube (SST) for serum collection
Units
N/A
Ref low
0
Ref high
1
Critical range
— – 200 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
Immunofluorescence Assay (IFA)
CPT
86638
SNOMED
122450008
Specimen volume
1–2 mL serum
Stability
Refrigerated (2–8°C): up to 7 days; Frozen (-20°C or below): up to 30 days; Avoid repeated freeze-thaw cycles
Hemolysis max
100
Lipemia max
100
Icterus max
50
TAT
24–72 hours
Order
routine

What This Test Measures

The test measures the presence of Immunoglobulin G (IgG) antibodies against *Borrelia burgdorferi* in your serum or plasma. These antibodies develop after your immune system has encountered the bacterium, typically within weeks to months after infection. The fluorescent immunoassay detects these antibodies by binding them to labeled probes, producing a measurable signal if antibodies are present.

Why It’s Done

Your healthcare provider may order this test if you have symptoms like fever, rash (e.g., bull’s-eye rash), joint pain, or neurological issues (e.g., meningitis) that could suggest Lyme disease. It’s also used to confirm a diagnosis after initial testing or monitor treatment progress.

How It’s Done

A blood sample is drawn from a vein in your arm. The serum or plasma is then tested in a lab using fluorescent immunoassay, where antibodies bind to labeled antigens. A fluorescent signal indicates a positive result if antibodies are detected.

What the Results Mean

A positive result suggests past or current infection with *Borrelia burgdorferi*. However, false positives can occur, especially in people with other infections or autoimmune conditions. A negative result means no detectable antibodies were found, but it doesn’t rule out Lyme disease definitively if symptoms persist.

Reference range

Negative: <1:16; Past exposure: 1:16–1:64; Active/recent infection: ≥1:128 (Phase 2 IgG titer)N/A

Specimen: serum

No fasting required. Patients should inform their healthcare provider about any recent antibiotic use, immunosuppressive therapy, or underlying conditions such as valvular heart disease, vascular grafts, or pregnancy that may increase risk of chronic Q fever.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

IgG Anti-Borrelia Test

Frequently asked questions

What does a positive result imply?
A positive IgG anti-Borrelia test indicates your immune system has likely encountered the bacterium. This may mean you had Lyme disease at some point, even if symptoms were mild or resolved. However, ongoing symptoms (e.g., joint pain, fatigue) could warrant further testing or treatment, as Lyme disease can sometimes cause long-term effects.
What if my symptoms persist after a negative test?
A negative result doesn’t always mean you’re clear of infection. Lyme disease can sometimes cause delayed antibody production, especially if symptoms are early or untreated. Your provider may recommend additional tests (e.g., IgM antibodies, PCR, or other serology) or retesting if symptoms continue, as early treatment is key to preventing complications.
Can this test be used for early Lyme disease?
No, this IgG test is not ideal for early Lyme disease detection. Antibodies typically take weeks to months to develop after infection. For early diagnosis, providers may use IgM testing or clinical correlation with symptoms and risk factors (e.g., tick exposure).
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy